2002
DOI: 10.1016/s0161-813x(02)00062-1
|View full text |Cite
|
Sign up to set email alerts
|

Alteration of Intracellular Structure and Function of Glyceraldehyde-3-Phosphate Dehydrogenase: A Common Phenotype of Neurodegenerative Disorders?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
48
0
3

Year Published

2003
2003
2013
2013

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 79 publications
(53 citation statements)
references
References 59 publications
2
48
0
3
Order By: Relevance
“…Furthermore the treated cells showed a marked increase of the expression of both glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and enolase. These two proteins are involved in energy metabolism and Gapdh has also been shown to bind the β-amyloid precursor protein [18] and to be involved in transcriptional regulation of cell-cycle [19]. Finally, we observed an increase in the expression level of actin as previously shown in cell exposed to the intracellular domain of the β-amyloid precursor protein [20].…”
Section: Biochimica Et Biophysica Acta 1794 (2009) 1243-1250supporting
confidence: 83%
See 1 more Smart Citation
“…Furthermore the treated cells showed a marked increase of the expression of both glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and enolase. These two proteins are involved in energy metabolism and Gapdh has also been shown to bind the β-amyloid precursor protein [18] and to be involved in transcriptional regulation of cell-cycle [19]. Finally, we observed an increase in the expression level of actin as previously shown in cell exposed to the intracellular domain of the β-amyloid precursor protein [20].…”
Section: Biochimica Et Biophysica Acta 1794 (2009) 1243-1250supporting
confidence: 83%
“…Furthermore, increased expression and nuclear translocation of Gapdh have recently been reported to participate to the apoptotic pathway in different cell types [44][45][46][47]. Finally, Gapdh has also been reported to bind to a variety of proteins involved in neuronal diseases, including the amyloid precursor protein and huntingtin [18]. The increased levels of actin expression in cells exposed to prefibrillar HypF-N aggregates are similar to the effects previously reported by Muller et al; these authors found up-regulation of the actin gene expression in cells harbouring the cytoplasmic domain of the amyloid precursor protein [20].…”
Section: Discussionmentioning
confidence: 99%
“…We previously demonstrated that GAPDH is a member of a protein complex that recognizes modified DNA (15), and this complex was destroyed by an anti-GAPDH monoclonal antibody (15). Although protein-protein interacting domains within GAPDH, other than those involved in oligomerization, have not been defined, GAPDH is known to form a variety of protein-protein complexes (15,22). Selective binding of GAPDH to ␤-amyloid precursor protein, huntingtin, ␣-synuclein, parkin, atrophin, ataxin-1, and androgen receptor indicate a potential role of GAPDH in neurodegenerative diseases associated with expansion of CAG repeats (4,22).…”
Section: Discussionmentioning
confidence: 99%
“…Although protein-protein interacting domains within GAPDH, other than those involved in oligomerization, have not been defined, GAPDH is known to form a variety of protein-protein complexes (15,22). Selective binding of GAPDH to ␤-amyloid precursor protein, huntingtin, ␣-synuclein, parkin, atrophin, ataxin-1, and androgen receptor indicate a potential role of GAPDH in neurodegenerative diseases associated with expansion of CAG repeats (4,22). This proclivity to form multiprotein complexes led us to speculate that its partner proteins may play an important role in determining multiple biological functions of GAPDH within the cell.…”
Section: Discussionmentioning
confidence: 99%
“…Two hypotheses may explain our results: GAPDH is undergoing posttranslational modifications and/or degradation in the normal tissue or GAPDH is modified and accumulates at detectable levels in the ccRCC tissue, whereas in the normal tissue it is present at undetectable levels. Previous works suggest that GAPDH is indeed target of modifications that can modulate its cellular level (12,13).…”
Section: Discussionmentioning
confidence: 99%